Serum Metabolomic Profiles Identify ER-Positive Early Breast Cancer Patients at Increased Risk of Disease Recurrence in a Multicenter Population

PURPOSE: Detecting signals of micrometastatic disease in patients with early breast cancer (EBC) could improve risk stratification and allow better tailoring of adjuvant therapies. We previously showed that postoperative serum metabolomic profiles were predictive of relapse in a single-center cohort...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Clin Cancer Res
Huvudupphovsmän: Hart, Christopher D., Vignoli, Alessia, Tenori, Leonardo, Uy, Gemma Leonora, Van To, Ta, Adebamowo, Clement, Hossain, Syed Mozammel, Biganzoli, Laura, Risi, Emanuela, Love, Richard R., Luchinat, Claudio, Di Leo, Angelo
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2017
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5695865/
https://ncbi.nlm.nih.gov/pubmed/28082280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-1153
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk